CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 217 filers reported holding CHEMOCENTRYX INC in Q3 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,005,000 | -33.4% | 19,455 | -68.0% | 0.06% | -46.0% |
| Q2 2022 | $1,508,000 | +326.0% | 60,875 | +330.7% | 0.11% | +391.3% |
| Q1 2022 | $354,000 | +14.9% | 14,135 | +84.3% | 0.02% | -82.3% |
| Q1 2020 | $308,000 | +31.6% | 7,669 | -77.7% | 0.13% | +49.4% |
| Q3 2019 | $234,000 | -9.7% | 34,460 | +23.7% | 0.09% | -9.4% |
| Q2 2019 | $259,000 | +48.9% | 27,860 | +122.4% | 0.10% | -3.0% |
| Q1 2019 | $174,000 | -79.5% | 12,526 | -83.9% | 0.10% | -58.1% |
| Q4 2018 | $847,000 | -34.5% | 77,671 | -24.1% | 0.24% | -15.4% |
| Q3 2018 | $1,293,000 | +2.5% | 102,281 | +6.8% | 0.28% | +6.5% |
| Q2 2018 | $1,261,000 | – | 95,784 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |